AFT Pharmaceuticals Ltd. (AU:AFP) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
AFT Pharmaceuticals has announced a collaboration with European partners to finalize the development of a novel injectable medicine targeting a significant global market. The agreement involves a Phase III clinical trial with shared costs and potential for early income through out-licensing. The medicine, which offers a single-dose advantage over existing treatments, is expected to reach the market within three years.
For further insights into AU:AFP stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue